MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.470
+0.020 (1.38%)
At close: Nov 26, 2025, 4:00 PM EST
1.470
0.00 (0.01%)
After-hours: Nov 26, 2025, 7:46 PM EST
MIRA Pharmaceuticals Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for MIRA Pharmaceuticals in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for MIRA Pharmaceuticals.
Recommendation Trends
| Rating | Aug '24 | Sep '24 |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +1,056.46% | Sep 30, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +648.30% | Aug 5, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.38
from -0.51
EPS Next Year
-0.10
from -0.38
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | n/a | n/a |
| Avg | n/a | n/a |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.32 | 0.23 |
| Avg | -0.38 | -0.10 |
| Low | -0.43 | -0.40 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.